Updates for Patients and Communities CADTH is pleased to announce the membership of its new Patient and Community Advisory Committee. Twelve individuals from across the country have been invited to...

New CADTH Pharmaceutical Reviews Update CADTH is pleased to announce the launch of the CADTH Pharmaceutical Reviews Update, a new consolidated publication that will be used to communicate updates to...

Updates for Patients and Communities We received 85 nominations to CADTH’s new Patient and Community Advisory Committee. Patients, caregivers, and community members from Prince Edward Island, New...

CADTH Program Updates Common Drug Review (CDR) 1. New Template for Requesting Reconsideration CADTH has created a new standardized template for reconsideration requests on the basis that the CADTH...

Updates for Patients and Communities If you missed today’s webinar “Ensuring Patient Voices Are Heard: How Patients Can Contribute to the CADTH Symposium,” it will also be available in Events Archives...

CADTH Program Updates CADTH pan-Canadian Oncology Drug Review (pCODR) 1. Upcoming Webinar on CADTH/pCODR Clinician Input and Feedback Process In collaboration with Innovative Medicines Canada’s Joint...

CADTH Program Updates Common Drug Review 1. Additional Embargo Period Following Revised CDEC Recommendations Effective immediately, CADTH has revised its procedures for the CADTH Common Drug Review to...

CADTH Program Updates 1.New Aligned Recommendation Template As part of our ongoing initiative to align our reimbursement review processes, CADTH has revised the format of our recommendations reports...

CADTH Program Updates 1. COVID-19 Update CADTH continues to support health care decision-makers throughout this challenging period. We have established a new website with information related to COVID...

Updates for Patients and Communities CADTH understands that patients and patient groups may have new or heightened responsibilities (both personally and professionally) as a result of the COVID-19...